Immunotherapy Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Report Code: ZMR-1811 | Report Format : | Status : Upcoming |

Abstract

Global Immunotherapy Drugs Market: Overview

Previously, cancer was treated with chemotherapy, radiation therapy, and sometimes with the help of surgery. Recently, many advanced treatments have emerged in the field of immuno-oncology. The aim of the next generation cancer treatment is to adopt improved techniques of anticancer therapy. Immunotherapy is a biological therapy in which human immunity system is improved to fight against infectious diseases and cancer. This treatment enhances the overall immunity of the body and restricts the growth of the cancer cells. In this treatment, immune cells kill the cancer cells from the body.

Global Immunotherapy Drugs Market: Growth Factors

Rising occurrences of the autoimmune diseases, cancer, and others along with increasing demand for the immunotherapy drugs is anticipated to fuel the immunotherapy drugs market growth. Increasing need for immunotherapy drugs and mAbs is expected to drive the market growth. mAbs possess high resemblance towards the specific disease and areas that require treatment. Immunotherapy drugs are utilized for therapies such as radioimmunotherapy and antibody-directed enzyme prodrug therapy. These antibodies are increasingly used in the development process, thus expecting to enhance the market revenue in the coming years. Materialization of biosimilars is another driving factor for the immunotherapy drugs market.

Global Immunotherapy Drugs Market: Segmentation

The immunotherapy drugs market is classified into therapy area, type of drug, and region. The therapy area is divided into infectious diseases, cancer, autoimmune & inflammatory diseases, and others. The cancer segment is further sub-segmented into the malignant and solid tumor. Depending on the type of drug, the market is fragmented into checkpoint inhibitors, checkpoint inhibitors, monoclonal antibodies, interleukins, adult vaccines, interferons alpha & beta, and others. The adult vaccine is sub-segmented into therapeutic vaccines and preventive vaccines. Region wise, the market is diversified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Global Immunotherapy Drugs Market: Regional Analysis

North America is expected to contribute the largest market share, whereas Asia Pacific will be the fastest growing region for immunotherapy drugs. Favorable government initiatives, availability of technologically advanced health care research framework, personalized medicine, healthy R&D investment, and development of next generation sequencing are some of the key factors responsible for the growth of immunotherapy drugs in North America. Low cost of manufacturing coupled with an acceptable regulatory scenario in this region may give rise to the market growth. Prosperous middle class willing to spend on quality healthcare products along with the presence of a vast pool of geriatric population in Asia Pacific region anticipate emerging as a most promising investment destination for the immunotherapy drugs. High disposable income, development of health care infrastructure, largely untapped market base, the rise in health and hygiene related awareness, and economic development in Asia Pacific region is expected to augment the immunotherapy drugs market growth in future.

Global Immunotherapy Drugs Market: Competitive Players

Major market players in the global immunotherapy drugs market include F. Hoffmann-La Roche, Merck, AbbVie, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, Alder Biopharmaceuticals, ChemoCentryx, Boehringer Ingelheim, and Amgen. Other prominent players include Argos Therapeutics, Agenus, CTI BioPharma, AVAX Technologies, ADC Therapeutics, Agensys, Biothera, Biogen, Aduro Biotech, Acorda Therapeutics, Eli Lilly, Advaxis, Coherus BioSciences, and Bavarian Nordic.

Global Immunotherapy Drugs Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Report Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Immuno-oncology Therapy Market by Therapy Type (Monoclonal Antibodies, Immune Checkpoint Inhibitors (PD-1/PD-L1 and CTLA-4), Immune System Modulators, and Cancer Vaccines) and by Therapeutic Areas, for Hospitals, Clinics, ASC’s and Cancer Research Institutes: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Jan-2018 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2534 | Report Format:

The report covers forecast and analysis for the immuno-oncology therapy market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the immuno-oncology therapy mar...Read More

Compounding Pharmacies Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2525 | Report Format:

Global Compounding Pharmacies Market: Overview Compounding is the knowledge of preparing and combining tailored medicines for users. These medicines are made on the basis of the prescription from the practitioner wherein, the separate ingredients are blended together according to the recommended...Read More

Antithrombin Market by (Source- Human, and Goat Milk; Application - Diagnostics, Therapeutics, and Research; Dosage Form- Liquid and Lyophilized): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2514 | Report Format:

The report covers forecast and analysis for the antithrombin market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the antithrombin market along with the imp...Read More

Alzheimer’s Drugs Market by Drug Class (Cholinergic, Memantine and Combined Drug), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Sales), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2513 | Report Format:

The report covers forecast and analysis for the Alzheimers drugs market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the Alzheimers drugs market along ...Read More

Non-Invasive Prenatal Testing (NIPT) Market by Test Type (Panel 1, Panel 2 and Panel 3) and End-users (Hospitals, Diagnostic Centers and Maternity Clinics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2512 | Report Format:

The report covers forecast and analysis for the non-invasive prenatal testing (NIPT) market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the non-invasive p...Read More

Choose License Type:
Latest Published Reports

View All Published Reports